The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
Go back to The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.13 -0.13 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.26 | 52 Week High | $7.47 | |||
| Open | $5.27 | 52 Week Low | $7.47 | |||
| Day High | $5.27 | P/E | N/A | |||
| Day Low | $5.13 | EPS | $0.00 | |||
| Volume | 108,906 | |||||
